SCHEMBL3715656

SCHEMBL3715656

CCc1cc(Br)cc(CC)c1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.41
SIGMAR1 Q99720 2/20 0.38
DGAT1 O75907 1/20 0.34
POLB P06746 2/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
CYP1A2 P05177 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAP2K1 Q02750 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GPR35 Q9HC97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328457 0.80 PTPN1 (0.40) POLBGABRA1GABRB2CYP1A2MEN1
SCHEMBL2850885 0.80 MEN1 (0.47) PARP1SIGMAR1POLBMEN1KMT2A
SCHEMBL580070 0.80 POLB (0.39) PARP1SIGMAR1POLBCYP1A2MEN1
SCHEMBL21633060 0.76 MAPT (0.38) PARP1DGAT1POLBGABRA1GABRB2
SCHEMBL4446190 0.74 DGAT1 (0.56) PARP1DGAT1CYP1A2KMT2AKDM4E
SCHEMBL9871803 0.74 KDM4E (0.44) CYP1A2MEN1KMT2AKDM4EALDH1A1
SCHEMBL580709 0.73 GABRA1 (0.52) PARP1GABRA1GABRB2KDM4EALDH1A1
SCHEMBL1104463 0.73 POLB (0.48) PARP1DGAT1POLBCYP1A2MEN1
SCHEMBL8570084 0.72 NOTUM (0.41) SIGMAR1TSHRKDM4EALDH1A1
SCHEMBL20504963 0.72 GPR17 (0.36) DGAT1POLBGABRA1GABRB2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2417125-B1 N-ARYL-2-(2-ARYLAMINOPYRIMIDIN-4-YL)PYRROL-4-CARBOXAMIDE DERIVATIVES AS MPS1 KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2015-09-09 EP claimed
US-8772280-B2 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as MPS1 kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-07-08 US claimed
WO-2010108921-A1 N-ARYL-2-(2-ARYLAMINOPYRIMIDIN-4-YL)PYRROL-4-CARBOXAMIDE DERIVATIVES AS MPS1 KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-09-30 WO claimed
EP-2417125-B1 N-ARYL-2-(2-ARYLAMINOPYRIMIDIN-4-YL)PYRROL-4-CARBOXAMIDE DERIVATIVES AS MPS1 KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2015-09-09 EP disclosed
US-8772280-B2 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as MPS1 kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2014-07-08 US disclosed
WO-2010108921-A1 N-ARYL-2-(2-ARYLAMINOPYRIMIDIN-4-YL)PYRROL-4-CARBOXAMIDE DERIVATIVES AS MPS1 KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-09-30 WO disclosed